<address id="cansv"></address>
<s id="cansv"><sub id="cansv"></sub></s>
    <s id="cansv"></s>
    <span id="cansv"><input id="cansv"></input></span>
      <label id="cansv"></label>
      <s id="cansv"></s>

      <strike id="cansv"></strike>

      1. <s id="cansv"><sub id="cansv"><rt id="cansv"></rt></sub></s>
      2. <label id="cansv"></label>
      3. 掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
          
        客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  關于我們  聯系我們
        產品中心-北京博奧森生物技術有限公司
        Recombinant SARS-Cov-2 Spike S1 protein (N501Y), His (HEK293) (bs-46012P)  
        訂購熱線:400-901-9800
        訂購郵箱:sales@bioss.com.cn
        訂購QQ:  400-901-9800
        技術支持:techsupport@bioss.com.cn
        100ug/3980.00元
        500ug/12500.00元
        1mg/38000.00元
        大包裝/詢價
        產品編號 bs-46012P
        英文名稱 Recombinant SARS-Cov-2 Spike S1 protein (N501Y), His (HEK293)
        中文名稱 重組SARS冠狀病毒2 Spike突變蛋白S1(N501Y) His tag
        別    名 SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; SPIKE_SARS2; 2019-nCOV Spike protein(N501Y), Recombinant (His Tag); Recombinant SARS-COV-2 S protein S1(N501Y) Protein. ;Recombinant SARS-Cov-2 Spike S1 protein (N501Y), His (HEK293)  突變型新冠蛋白; 新冠病毒S蛋白突變體(N501Y); 重組新冠病毒 Spike突變蛋白S1(N501Y); 新型冠狀病毒Spike突變體蛋白;
        克 隆 號
        理論分子量 129 kDa
        檢測分子量 120-140
        性    狀 Lyophilized or Liquid
        濃    度 >0.5 mg/ml
        物    種 SARS-Cov-2
        序    列 16-1188/1273
        純    度 >95% as determined by SDS-PAGE
        純化方法 AC
        內毒素 Not analyzed
        表達系統 HEK293 cell
        活性 Yes
        標簽 His
        緩 沖 液 Lyophilized from 0.22um filtered solution in PBS (pH7.4). Normally 5% trehalose is added as protectant before lyophilization.
        保存條件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
        注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
        產品介紹 A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat.It is characterised by multiple mutations in the spike protein. Among them, N501Y is of major concern because it involves one of the six key amino acid residues determining a tight interaction of the SARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme 2 (ACE2).

        版權所有 2004-2026 m.radiasunchina.com 北京博奧森生物技術有限公司
        通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
        通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
        京ICP備05066980號-1         京公網安備110107000727號
        国产剧情演绎系列丝袜高跟|一级毛片av性爱黄色网站|欧美三级午夜理伦三级|国产av巨作情欲放纵|亚洲 欧美 中文 日韩aⅴ
        <address id="cansv"></address>
        <s id="cansv"><sub id="cansv"></sub></s>
        <s id="cansv"></s>
        <span id="cansv"><input id="cansv"></input></span>
          <label id="cansv"></label>
          <s id="cansv"></s>

          <strike id="cansv"></strike>

          1. <s id="cansv"><sub id="cansv"><rt id="cansv"></rt></sub></s>
          2. <label id="cansv"></label>